KB Financial Partners’s Gilead Sciences GILD Stock Holding History

KB Financial Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$371K	Buy	4,946 +79	+2%	+$6.08K	0.11%	122
2023 Q2	$375K	Sell	4,867 -5,937	-55%	-$474K	0.1%	126
2023 Q1	$896K	Sell	10,804 -381	-3%	-$31.6K	0.26%	34
2022 Q4	$960K	Sell	11,185 -1,080	-9%	-$85.5K	0.33%	32
2022 Q3	$757K	Buy	12,265 +1,792	+17%	+$113K	0.27%	38
2022 Q2	$647K	Sell	10,473 -654	-6%	-$40.5K	0.22%	40
2022 Q1	$662K	Buy	11,127 +2,051	+23%	+$131K	0.18%	46
2021 Q4	$659K	Buy	+9,076	New	+$625K	0.19%	44
2021 Q3	–	Sell	-2,273	Closed	-$157K	–	323
2021 Q2	$157K	Buy	2,273 +2,150	+1,748%	+$144K	0.06%	179
2021 Q1	$8K	Buy	+123	New	+$7.93K	﹤0.01%	462

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

KB Financial Partners's GILD Position: Q3 2023 in Review

KB Financial Partners increased its Gilead Sciences (GILD) stake by 1.6% in Q3 2023, buying an estimated $6.08K and bringing the position to 4,946 shares worth $371K. The position accounts for 0.11% of the portfolio, ranked #122.

KB Financial Partners first reported a position in GILD in Q1 2021 and has held it in 10 quarters since. The position peaked at $960K in Q4 2022. 1,681 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

KB Financial Partners held 4,946 shares of Gilead Sciences worth $371K as of Q3 2023.
KB Financial Partners bought 79 Gilead Sciences shares in Q3 2023, an estimated $6.08K.
Gilead Sciences made up 0.11% of KB Financial Partners's portfolio in Q3 2023, its #122 holding.
KB Financial Partners first reported a position in Gilead Sciences in Q1 2021 and has held it in 10 quarters since.
KB Financial Partners's Gilead Sciences position peaked at $960K in Q4 2022.
1,681 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on KB Financial Partners's 13F filing for Q3 2023, filed 15 Nov 2023.